|Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome|
RW Tothill, AV Tinker, J George, R Brown, SB Fox, S Lade, DS Johnson, ...
Clinical cancer research 14 (16), 5198-5208, 2008
|Whole–genome characterization of chemoresistant ovarian cancer|
AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ...
Nature 521 (7553), 489-494, 2015
|Next-generation sequencing for cancer diagnostics: a practical perspective|
C Meldrum, MA Doyle, RW Tothill
The Clinical Biochemist Reviews 32 (4), 177, 2011
|Options available—from start to finish—for obtaining data from DNA microarrays II|
AJ Holloway, RK Van Laar, RW Tothill, DDL Bowtell
Nature genetics 32 (4), 481-489, 2002
|CONTRA: copy number analysis for targeted resequencing|
J Li, R Lupat, KC Amarasinghe, ER Thompson, MA Doyle, GL Ryland, ...
Bioinformatics 28 (10), 1307-1313, 2012
|Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas|
D Etemadmoghadam, A Defazio, R Beroukhim, C Mermel, J George, ...
Clinical cancer research 15 (4), 1417-1427, 2009
|Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis|
S Moran, A MartÝnez-Card˙s, S Sayols, E MusulÚn, C Bala˝ß, ...
The Lancet Oncology 17 (10), 1386-1395, 2016
|An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin|
RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK Van Laar, ...
Cancer research 65 (10), 4031-4040, 2005
|Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles|
ER Thompson, MA Doyle, GL Ryland, SM Rowley, DYH Choong, ...
PLoS Genet 8 (9), e1002894, 2012
|UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas|
SQ Wong, K Waldeck, IA Vergara, J Schr÷der, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
|Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells|
L Pirola, A Balcerczyk, RW Tothill, I Haviv, A Kaspi, S Lunke, M Ziemann, ...
Genome research 21 (10), 1601-1615, 2011
|BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage|
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
|Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors|
MS Anglesio, JM Arnold, J George, AV Tinker, R Tothill, N Waddell, ...
Molecular cancer research 6 (11), 1678-1690, 2008
|An evolutionarily conserved function of polycomb silences the MHC Class I antigen presentation pathway and enables immune evasion in cancer|
ML Burr, CE Sparbier, KL Chan, YC Chan, A Kersbergen, EYN Lam, ...
Cancer Cell 36 (4), 385-401. e8, 2019
|68 Ga-DOTATATE and 18 F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity|
CA Chang, DA Pattison, RW Tothill, G Kong, TJ Akhurst, RJ Hicks, ...
Cancer Imaging 16 (1), 1-12, 2016
|Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary|
RW Tothill, J Li, L Mileshkin, K Doig, T Siganakis, P Cowin, A Fellowes, ...
The Journal of pathology 231 (4), 413-423, 2013
|Loss of heterozygosity: what is it good for?|
GL Ryland, MA Doyle, D Goode, SE Boyle, DYH Choong, SM Rowley, J Li, ...
BMC medical genomics 8 (1), 1-12, 2015
|Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads|
J Schr÷der, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ...
Bioinformatics 30 (8), 1064-1072, 2014
|The genomic landscape of phaeochromocytoma|
A Flynn, D Benn, R Clifton‐Bligh, B Robinson, AH Trainer, P James, ...
The Journal of pathology 236 (1), 78-89, 2015
|A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response|
RA Busuttil, J George, RW Tothill, K Ioculano, A Kowalczyk, C Mitchell, ...
Clinical cancer research 20 (10), 2761-2772, 2014